|
WO2006014156A1
|
|
Systems and methods for isolating and using clinically safe adipose derived regenerative cells
|
|
CN102204928A
|
|
Application of regenerative cells to promoting wound healing
|
|
MXPA06003088A
|
|
Methods of using regenerative cells in the treatment of peripheral vascular disease and related disorders.
|
|
WO2006014158A1
|
|
Treating disorders by administering regenerative cells.
|
|
CN1842589A
|
|
Systems and methods for separating and concentrating regenerative cells from tissue
|
|
WO2004110502A2
|
|
Helical endoluminal stent and related methods
|
|
CN1901802A
|
|
Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions
|
|
BRPI0407694A
|
|
Methods of Using Fat-Derived Cells in the Treatment of Cardiovascular Conditions
|
|
EP1594427A2
|
|
Resorbable radiopaque markers and related medical implants
|
|
CN1703174A
|
|
Apparatus for preventing adhesions between an implant and surrounding tissues
|
|
WO2004010851A2
|
|
Resorbable thin membranes
|
|
CN1738579A
|
|
Resorbable thin membranes
|
|
CA2419831A1
|
|
Methods for governing bone growth
|
|
AU2002326901B2
|
|
Preservation of non embryonic cells from non hematopoietic tissues
|
|
US6719795B1
|
|
Resorbable posterior spinal fusion system
|
|
US6635064B2
|
|
Non-scatterable, radio-opaque material for medical imaging applications
|
|
US6712851B1
|
|
Resorbable, macro-porous non-collapsing and flexible membrane barrier for skeletal repair and regeneration
|
